# The Menopause After Cancer Study

> **NCT04766229** · PHASE2 · COMPLETED · sponsor: **University College Dublin** · enrollment: 205 (actual)

## Conditions studied

- Menopause
- Cancer
- Insomnia

## Interventions

- **COMBINATION_PRODUCT:** Citalopram +/- Gabapentin + Sleepio + support person

## Key facts

- **NCT ID:** NCT04766229
- **Lead sponsor:** University College Dublin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-21
- **Primary completion:** 2022-11-30
- **Final completion:** 2022-11-30
- **Target enrollment:** 205 (ACTUAL)
- **Last updated:** 2023-01-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04766229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04766229, "The Menopause After Cancer Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04766229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*